U.S. Markets open in 15 hrs, 49 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,288.54 | 73.03 | 0.65% |
| NASDAQ | 2,245.38 | -6.08 | -0.27% |
| S&P 500 | 1,262.90 | 1.38 | 0.11% |
| Day Low 10:04 AM EDT | 4.38 | |
|---|---|---|
| Day High 10:37 AM EDT | 4.53 |
|
| Range | 0.15 | |
| Volume | 433,363 | |
| 30-Day Avg. Vol. | 1.15 M |
|
| Difference | -62.45% | |
| Market Cap. | 413.79 M | |
| Change | -5.59 M | |
| Shares Out. | 93.19 M | |
| Percent Traded | 0.47% | |
| Revenue | 743,000 | |
| Earnings | -99.26 M | |
| EPS (TTM) | -1.05 |
| 52-Wk Low 3/17/08 | 4.15 | |
|---|---|---|
| 52-Wk High 9/11/07 | 8.56 |
|
| Range | 4.41 | |
| Prev. Close 7/2/08 | 4.50 | |
| Today's Open | 4.48 | |
| Change | -0.44% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 1.7394 | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | — |
Dendreon wants to boost your immunity from the start. It is developing therapeutic vaccines that goose the body's immune system to help it fight cancer by targeting dendritic cells, which initiate an immune ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.248 12/31/07 | -0.32 12/31/07 |
-0.072
Missed
|
| Last Quarter | -0.246 3/31/08 | -0.23 3/31/08 |
0.016
Beat
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 31,000.00 | 743,000.00 |
| Gross Profit | — | -5.50 M |
| Operating Income | -17.21 M | -99.28 M |
| Net Income | -19.52 M | -99.26 M |
